Ledger.Open graph →
SEC Form D · filed September 15, 2014

Clearside Biomedical, Inc

Offering
$20.0M
Sold
$16.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Alpharetta, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Clay H. Thorp · Durham, NCDirectorScott F. Schaeffer · Philadelphia, PADirectorGlenn D. Noronha · Alpharetta, GAExecWilliam C. Dunkelberg · Philadelphia, PADirectorChristy H. Shaffer · Durham, NCDirector · PromoterCharles A. Deignan · Alpharetta, GAExecNate K. Redmond · SANTA MONICA, CADirectorRichard Lowenthal · Campbell, CADirectorStephen Socolof · San Jose, CADirector · PromoterJohn Stockton · San Jose, CADirectorAlbert Hu · LOS ALTOS HILLS, CAExecDaniel H. White · Alpharetta, GAExec · Director · PromoterCharles A. Deignan · Alpharetta, GAExecEvgeny D. Zaytsev · Palo Alto, CADirectorMark H. Prausnitz · Atlanta, GADirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗